Can a daily pill keep brain lymphoma at bay after remission?
Disease control
Recruiting now
This trial is testing whether taking tirabrutinib daily can help people with primary central nervous system lymphoma (PCNSL) stay in remission longer after their initial chemotherapy has worked. Participants who have achieved complete remission will be randomly assigned to receiv…
Phase: PHASE2 • Sponsor: Kyorin University • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC